
Long-term ibrutinib-rituximab vs FCR in CLL, procoagulant platelet sentinels in prevention of inflammatory bleeding, and new SERPINC1 variants in thrombophilia
Blood Podcast
00:00
Introduction
Blood podcast is your source for innovative ideas and cutting edge information. To day, we'll compare the long term outcomes of ibrutin retuximab combination therapy versus f c r cimo muno therapy in chronic lymphositic lucemia. We also discuss the role of pro coagulant platelet sentinels in inflammatory bleeding,. And learn more about variants in the serpent sangen coting anti thrombin that caused severe thrombo pilia.
Transcript
Play full episode